TREX1
From Wikipedia, the free encyclopedia
Three prime repair exonuclease 1
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | TREX1; AGS1; ATRIP; DKFZp434J0310; DRN3; FLJ12343 | |||||||||||||
External IDs | OMIM: 606605 MGI: 1925349 HomoloGene: 15601 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 11277 | 235610 | ||||||||||||
Ensembl | ENSG00000164053 | ENSMUSG00000025646 | ||||||||||||
Uniprot | Q9NSU2 | Q66L37 | ||||||||||||
Refseq | NM_016381 (mRNA) NP_057465 (protein) |
NM_172774 (mRNA) NP_766362 (protein) |
||||||||||||
Location | Chr 3: 48.46 - 48.48 Mb | Chr 9: 108.92 - 108.93 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Three prime repair exonuclease 1, also known as TREX1, is a human gene.[1]
This gene encodes the major 3'->5' DNA exonuclease in human cells. The protein is a non-processive exonuclease that may serve a proofreading function for a human DNA polymerase. It is also a component of the SET complex, and acts to rapidly degrade 3' ends of nicked DNA during granzyme A-mediated cell death. Mutations in this gene result in Aicardi-Goutieres syndrome, chilblain lupus, and Cree encephalitis. Multiple transcript variants encoding different isoforms have been found for this gene.[1]
[edit] References
[edit] Further reading
- Tolmie JL, Shillito P, Hughes-Benzie R, Stephenson JB (1996). "The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis).". J. Med. Genet. 32 (11): 881–4. PMID 8592332.
- Black DN, Watters GV, Andermann E, et al. (1989). "Encephalitis among Cree children in northern Quebec.". Ann. Neurol. 24 (4): 483–9. doi: . PMID 3239950.
- Perrino FW, Miller H, Ealey KA (1994). "Identification of a 3'-->5'-exonuclease that removes cytosine arabinoside monophosphate from 3' termini of DNA.". J. Biol. Chem. 269 (23): 16357–63. PMID 8206943.
- Goutières F, Aicardi J, Barth PG, Lebon P (1999). "Aicardi-Goutières syndrome: an update and results of interferon-alpha studies.". Ann. Neurol. 44 (6): 900–7. doi: . PMID 9851434.
- Mazur DJ, Perrino FW (1999). "Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'-->5' exonucleases.". J. Biol. Chem. 274 (28): 19655–60. PMID 10391904.
- Höss M, Robins P, Naven TJ, et al. (1999). "A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein.". EMBO J. 18 (13): 3868–75. doi: . PMID 10393201.
- Crow YJ, Jackson AP, Roberts E, et al. (2000). "Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21.". Am. J. Hum. Genet. 67 (1): 213–21. PMID 10827106.
- Mazur DJ, Perrino FW (2001). "Structure and expression of the TREX1 and TREX2 3' --> 5' exonuclease genes.". J. Biol. Chem. 276 (18): 14718–27. doi: . PMID 11278605.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Crow YJ, Black DN, Ali M, et al. (2003). "Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism.". J. Med. Genet. 40 (3): 183–7. PMID 12624136.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Unsal-Kaçmaz K, Mullen TE, Kaufmann WK, Sancar A (2005). "Coupling of human circadian and cell cycles by the timeless protein.". Mol. Cell. Biol. 25 (8): 3109–16. doi: . PMID 15798197.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi: . PMID 16189514.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55–65. doi: . PMID 16344560.
- Yoshioka K, Yoshioka Y, Hsieh P (2006). "ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.". Mol. Cell 22 (4): 501–10. doi: . PMID 16713580.
- Chowdhury D, Beresford PJ, Zhu P, et al. (2006). "The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death.". Mol. Cell 23 (1): 133–42. doi: . PMID 16818237.
- Crow YJ, Hayward BE, Parmar R, et al. (2006). "Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus.". Nat. Genet. 38 (8): 917–20. doi: . PMID 16845398.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi: . PMID 17081983.